MEDIPOST (Korea) Market Value

078160 Stock  KRW 11,500  300.00  2.68%   
MEDIPOST's market value is the price at which a share of MEDIPOST trades on a public exchange. It measures the collective expectations of MEDIPOST Co investors about its performance. MEDIPOST is trading at 11500.00 as of the 23rd of July 2025, a 2.68 percent increase since the beginning of the trading day. The stock's open price was 11200.0.
With this module, you can estimate the performance of a buy and hold strategy of MEDIPOST Co and determine expected loss or profit from investing in MEDIPOST over a given investment horizon. Check out MEDIPOST Correlation, MEDIPOST Volatility and MEDIPOST Alpha and Beta module to complement your research on MEDIPOST.
Symbol

Please note, there is a significant difference between MEDIPOST's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIPOST is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIPOST's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

MEDIPOST 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MEDIPOST's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MEDIPOST.
0.00
04/24/2025
No Change 0.00  0.0 
In 3 months and 1 day
07/23/2025
0.00
If you would invest  0.00  in MEDIPOST on April 24, 2025 and sell it all today you would earn a total of 0.00 from holding MEDIPOST Co or generate 0.0% return on investment in MEDIPOST over 90 days. MEDIPOST is related to or competes with Sungchang Autotech, Dongwon Metal, Jinro Distillers, and Amogreentech. MEDIPOST Co., Ltd. provides stem cell therapeutic solutions to meet the unmet medical needs in South Korea and internati... More

MEDIPOST Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MEDIPOST's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MEDIPOST Co upside and downside potential and time the market with a certain degree of confidence.

MEDIPOST Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for MEDIPOST's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MEDIPOST's standard deviation. In reality, there are many statistical measures that can use MEDIPOST historical prices to predict the future MEDIPOST's volatility.
Hype
Prediction
LowEstimatedHigh
11,49611,50011,504
Details
Intrinsic
Valuation
LowRealHigh
11,14611,15012,650
Details
Naive
Forecast
LowNextHigh
12,08412,08712,091
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
10,03511,60213,170
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as MEDIPOST. Your research has to be compared to or analyzed against MEDIPOST's peers to derive any actionable benefits. When done correctly, MEDIPOST's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in MEDIPOST.

MEDIPOST Backtested Returns

MEDIPOST appears to be very steady, given 3 months investment horizon. MEDIPOST has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13 % return per unit of risk over the last 3 months. By examining MEDIPOST's technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please exercise MEDIPOST's risk adjusted performance of 0.1214, and Mean Deviation of 2.81 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, MEDIPOST holds a performance score of 10. The company secures a Beta (Market Risk) of 0.22, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MEDIPOST's returns are expected to increase less than the market. However, during the bear market, the loss of holding MEDIPOST is expected to be smaller as well. Please check MEDIPOST's downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether MEDIPOST's current price movements will revert.

Auto-correlation

    
  -0.55  

Good reverse predictability

MEDIPOST Co has good reverse predictability. Overlapping area represents the amount of predictability between MEDIPOST time series from 24th of April 2025 to 8th of June 2025 and 8th of June 2025 to 23rd of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MEDIPOST price movement. The serial correlation of -0.55 indicates that about 55.0% of current MEDIPOST price fluctuation can be explain by its past prices.
Correlation Coefficient-0.55
Spearman Rank Test0.03
Residual Average0.0
Price Variance660.8 K

MEDIPOST lagged returns against current returns

Autocorrelation, which is MEDIPOST stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MEDIPOST's stock expected returns. We can calculate the autocorrelation of MEDIPOST returns to help us make a trade decision. For example, suppose you find that MEDIPOST has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

MEDIPOST regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MEDIPOST stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MEDIPOST stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MEDIPOST stock over time.
   Current vs Lagged Prices   
       Timeline  

MEDIPOST Lagged Returns

When evaluating MEDIPOST's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MEDIPOST stock have on its future price. MEDIPOST autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MEDIPOST autocorrelation shows the relationship between MEDIPOST stock current value and its past values and can show if there is a momentum factor associated with investing in MEDIPOST Co.
   Regressed Prices   
       Timeline  

Pair Trading with MEDIPOST

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MEDIPOST position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEDIPOST will appreciate offsetting losses from the drop in the long position's value.

Moving together with MEDIPOST Stock

  0.66005930 Samsung Electronics Earnings Call This WeekPairCorr
  0.65005935 Samsung Electronics Earnings Call This WeekPairCorr
  0.86000660 SK HynixPairCorr
  0.63011200 HMM CoPairCorr
  0.79000270 Kia Corp Earnings Call This WeekPairCorr
The ability to find closely correlated positions to MEDIPOST could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MEDIPOST when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MEDIPOST - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MEDIPOST Co to buy it.
The correlation of MEDIPOST is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MEDIPOST moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MEDIPOST moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MEDIPOST can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in MEDIPOST Stock

MEDIPOST financial ratios help investors to determine whether MEDIPOST Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MEDIPOST with respect to the benefits of owning MEDIPOST security.